Approval · Notice of Compliance 15648 · 2014
ELELYSO: Notice of Compliance 15648
Issued May 29, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15648
- Date
- May 29, 2014
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELELYSO | 02425637 | Cancelled Post Market |
Medicinal ingredients
- TALIGLUCERASE ALFA 200 UNIT per VIAL